Hepatocellular carcinoma in cirrhotic patients: Prospective comparison of US, CT and MR imaging

European Radiology

Volumn 23, Issue 4, 2013, Pages 887-896

  Di Martino, Michele ^a   De Filippis, Gianmaria ^a   De Santis, Adriano ^a   Geiger, Daniel ^a   Del Monte, Maurizio ^a   Lombardo, Concetta Valentina ^a   Rossi, Massimo ^a   Corradini, Stefano Ginanni ^a   Mennini, Gianluca ^a   Catalano, Carlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hepatocellular carcinoma; Liver specific contrast agent; Magnetic resonance imaging; Multidetector computed tomography; Ultrasound

Indexed keywords

GADOBENATE DIMEGLUMINE;

ARTICLE; COMPUTED TOMOGRAPHY SCANNER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 84878603066     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2691-z     Document Type: Article

References (37)

1. Yang JD, Roberts LR (2010) Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am 24:899-919
2. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300-4308
3. Gambarin-Gelwan M, David CD, Shapiro R et al. (2000) Sensitivity of commonly available screening test in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 95:1535-1538
4. Reinhold C, Hammers L, Taylor CR et al. (1995) Characterization of focal hepatic lesions with Duplex sonogrphy: findings in 198 patients. AJR Am J Roentgenol 164:1131-1135
5. Noguchi Y, Murakami T, Kim T et al. (2003) Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. AJR Am J Roentgenol 180:455-460
6. Kim YK, Kim CS, Chung GH et al. (2006) Comparison of gadobenate dimeglumine-enhanced MR and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol 186:149-157
7. Peterson MS, Baron RL, Marsh JW, Oliver JH III, Confer SR, Hunt LE (2000) Pretransplantation Surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 217:743-749
8. Sangiovanni A, Manini MA, Iavarone M et al. (2010) The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 59:638-644
9. Teefey SA, Hildeboldt CC, Dehdashti F et al. (2003) Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, PET. Radiology 226:533-542
10. Libbrecht L, Bielen D, Verslype C et al. (2002) Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 8:749-761
11. Freeman RB, Mithoefer A, Ruthazer R et al. (2006) Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 12:1504-1511
12. Boone JM (2006) Multidetector CT: opportunities, challenges, and concerns associated with scanners with 64 or more detector rows. Radiology 241:334-337
13. Marin D, Catalano C, De Filippis G et al. (2009) Detection of hepatocellular carcinoma in patients with cirrosi: added value of coronal multiplanar reformations from isotropix voxel with 64-MDCT. AJR Am J Roentgenol 192:775-782
14. D'Onofrio M, Faccioli N, Zamboni G et al. (2008) Focal liver lesions in cirrohosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels. Radiol Med 113:978-991
15. Baron RL, Oliver JH III, Confer S et al. (1997) Screening cirrhosis for hepatocellular carcinoma (HCC) with helical contrast CT: specificity. Radiology 2005:143
16. Bruix J, Scherman M, Llovet JM et al. (2001) Clinical managment of hepatocellular carcinoma. Conclusions of the barcellona-2000 EASL conference. Europe Assosation for the Study of the Liver. J Hepatol 35:421-430
17. Marin D, Di Martino M, Guerrisi A et al. (2009) Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT. Radiology 251:1-8
18. Kim JI, Lee MJ, Choi JY et al. (2008) The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular carcinoma nodules in the cirrhotic liver. Invest Radiol 43:202-210
19. Kim YK, Kim SC, Lee YH et al. (2004) Comaprison of superparamgnetic Iron Oxide-Enhanced and gadobenate dimeglumine-enhanced MRI for detection of small hepatocellular carcinomas. AJR Am J Roentgenol 182:1217-1223
20. Hammerstingl R, Huppertz A, Breuer J et al. (2008) Diagnostic efficacy of gadoxedic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraopeartive and histological findings in focal lilver lesions. Eur Radiol 18:457-467
21. Di Martino M, Marin D, Guerrisi G et al. (2010) Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the detection of hepatocellular carcinoma in patients with cirrhosis. Radiology 256:806-816
22. Ebara M, Hatano R, Fukuda H et al. (1998) Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepatogastroenterology 45:1214-1220
23. International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983-993
24. Harvey CJ, Albrecht T (2001) Ultrasound of focal liver lesions. Eur Radiol 11:1578-1593
25. Bruix J, Scherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236
26. Forner A, Vilana R, Ayuso C et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of non invasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97-104
27. Chakraborty DP (2006) Analysis of location specific observer performance data: validated extensions of the jackknife free-response (JAFROC) method. Acad Radiol 13:1187-1193
28. Schwnke C, Busse R (2007) Analysis of differences in proportions from clustered data with multiple measurements in disgnostic studies. Methods Inf Med 46:548-552
29. Bruix J, Scherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020-1022
30. Vogl TJ, Stupavsky A, Pegios W et al. (1997) Hepatocellular carcinoma: evaluation of dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopatologic correlation. Radiology 205:721-728
31. Grazioli L, Morana G, Caudana R et al. (2000) Hepatocellular Carcinoma: Correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 35:25-34
32. Morana G, Grazioli L, Kirchin MA et al. (2011) Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol 46:225-239
33. Choi B, Kim T, Han J et al. (2000) Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced scond harmonic versus color Doppler ultrasound. Radiology 214:167-172
34. Strobel D, Kleinecke C, Hänsler J et al. (2005) Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas - correlation with histological differentiation. Ultraschall Med 26:270-276
35. Dǎnilǎ M, Sporea I, Sirli R, Popescu A, Sendroiu M, Martie A (2010) The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis. Med Ultrason 12:145-149
36. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ (2010) Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 34:506-512
37. Bartolozzi C, Battaglia V, Bozzi E (2011) Hepatocellular nodules in liver cirrhosis: contrast enhanced MR. Abdom Imaging 36:290-299